![Christophe Hammer](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Christophe Hammer
Keine laufenden Positionen mehr
Profil
Christophe Hammer worked as a Product Manager at Aventis, Inc. and as a Principal at Berna Biotech AG.
He was also the Head of Regulatory Affairs at Kenta Biotech AG from 2010 to 2013.
He received his graduate degree from Boston University, his undergraduate degree from the University of Fribourg, and his doctorate from the Swiss Federal Institute of Technology.
Ehemalige bekannte Positionen von Christophe Hammer
Unternehmen | Position | Ende |
---|---|---|
Kenta Biotech AG
![]() Kenta Biotech AG BiotechnologyHealth Technology Kenta Biotech AG engages in the research, development, production, and marketing of biotechnological and pharmaceutical products. It also specializes in the discovery and development of monoclonal antibodies for the treatment of life-threatening hospital infections. The company was founded by Alois B. Lang on February 9, 2006 and is headquartered in Zug, Switzerland. | General Counsel | 01.01.2013 |
Aventis, Inc. | Corporate Officer/Principal | - |
Berna Biotech AG
![]() Berna Biotech AG Miscellaneous Commercial ServicesCommercial Services Berna Biotech AG produced and developed immunobiological preparations. It offered respiratory, hepatitis B, pediatric, veterinary and travel vaccines. The company was founded in 1898 and was headquartered in Bern, Switzerland | Corporate Officer/Principal | - |
Ausbildung von Christophe Hammer
Swiss Federal Institute of Technology | Doctorate Degree |
Boston University | Graduate Degree |
University of Fribourg | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 3 |
---|---|
Kenta Biotech AG
![]() Kenta Biotech AG BiotechnologyHealth Technology Kenta Biotech AG engages in the research, development, production, and marketing of biotechnological and pharmaceutical products. It also specializes in the discovery and development of monoclonal antibodies for the treatment of life-threatening hospital infections. The company was founded by Alois B. Lang on February 9, 2006 and is headquartered in Zug, Switzerland. | Health Technology |
Berna Biotech AG
![]() Berna Biotech AG Miscellaneous Commercial ServicesCommercial Services Berna Biotech AG produced and developed immunobiological preparations. It offered respiratory, hepatitis B, pediatric, veterinary and travel vaccines. The company was founded in 1898 and was headquartered in Bern, Switzerland | Commercial Services |
Aventis, Inc. |